Molecular cloning and characterization of human homeobox gene Nkx3.1 promoter. 2004

An-Li Jiang, and Jian-Ye Zhang, and Charles Young, and Xiao-Yan Hu, and Yong-Mei Wang, and Zhi-Fang Liu, and Mei-Lan Hao
Department of Biochemistry, School of medicine, Shandong University, Ji'nan 250012, China. zhjy@sdu.edu.cn

Nkx3.1 is a prostate-specific homeobox gene related strongly to prostate development and prostate cancer. To study its regulation of transcription, 1.06 kb 5' flanking region of Nkx3.1 gene and its 5' deletion mutants (861, 617, 417 and 238 bp) were obtained by PCR and cloned into pGL(3)-basic, a promoter-less luciferase reporter vector, to examine their promoter activities driving the reporter gene transcription. pRL-TK, a Renilla luciferase reporter vector was used as internal control, and pGL(3)-control and pGL(3)-basic were used as positive and negative control respectively. The promoter activities were determined by dualluciferase reporter assay 48 h after pGL(3) constructs were cotransfected with pRL-TK into prostate cancer cell LNCaP. The results showed that dual-luciferase reporter assay (M(1)/M(2)) of pGL(3)-1.06 kb cotransfection with pRL-TK was 2.7, which was about 1.5-fold higher than that of pGL(3)-control cotransfection with pRL-TK and 50-fold higher than that of pGL(3)-basic cotransfection with pRL-TK. The results also showed that the relative activities (M(1)/M(2)) were 0.71, 0.84, 0.44 and 2.07 respectively for pGL(3)-861 bp, pGL(3)-617 bp, pGL(3)-417 bp, pGL(3)-238 bp, the last one still had 80% promoter activity compared with pGL(3)-1.06 kb, which showed that deletion from 1.06 kb to 238 bp had small effects on promoter activity. The conclusion was that the 238 bp fragment containing a TATA box and two CAAT boxes had strong promoter activity. However, the deletion from 1.06 kb to 861 bp reduced activity 3.8-fold while the deletion from 417 bp to 238 bp enhanced activity 4.7-fold, which indicated that these deleted sequences might contain some important positive or negative regulatory elements. It will be important to identify the elements within the Nkx3.1 promoter that contribute to regulation of the gene transcription in the future studies.

UI MeSH Term Description Entries
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D016297 Mutagenesis, Site-Directed Genetically engineered MUTAGENESIS at a specific site in the DNA molecule that introduces a base substitution, or an insertion or deletion. Mutagenesis, Oligonucleotide-Directed,Mutagenesis, Site-Specific,Oligonucleotide-Directed Mutagenesis,Site-Directed Mutagenesis,Site-Specific Mutagenesis,Mutageneses, Oligonucleotide-Directed,Mutageneses, Site-Directed,Mutageneses, Site-Specific,Mutagenesis, Oligonucleotide Directed,Mutagenesis, Site Directed,Mutagenesis, Site Specific,Oligonucleotide Directed Mutagenesis,Oligonucleotide-Directed Mutageneses,Site Directed Mutagenesis,Site Specific Mutagenesis,Site-Directed Mutageneses,Site-Specific Mutageneses

Related Publications

An-Li Jiang, and Jian-Ye Zhang, and Charles Young, and Xiao-Yan Hu, and Yong-Mei Wang, and Zhi-Fang Liu, and Mei-Lan Hao
November 1996, Circulation research,
An-Li Jiang, and Jian-Ye Zhang, and Charles Young, and Xiao-Yan Hu, and Yong-Mei Wang, and Zhi-Fang Liu, and Mei-Lan Hao
July 1997, FEBS letters,
An-Li Jiang, and Jian-Ye Zhang, and Charles Young, and Xiao-Yan Hu, and Yong-Mei Wang, and Zhi-Fang Liu, and Mei-Lan Hao
September 2006, The Prostate,
An-Li Jiang, and Jian-Ye Zhang, and Charles Young, and Xiao-Yan Hu, and Yong-Mei Wang, and Zhi-Fang Liu, and Mei-Lan Hao
April 2002, FEBS letters,
An-Li Jiang, and Jian-Ye Zhang, and Charles Young, and Xiao-Yan Hu, and Yong-Mei Wang, and Zhi-Fang Liu, and Mei-Lan Hao
January 1996, Molecular medicine (Cambridge, Mass.),
An-Li Jiang, and Jian-Ye Zhang, and Charles Young, and Xiao-Yan Hu, and Yong-Mei Wang, and Zhi-Fang Liu, and Mei-Lan Hao
August 2001, Genomics,
An-Li Jiang, and Jian-Ye Zhang, and Charles Young, and Xiao-Yan Hu, and Yong-Mei Wang, and Zhi-Fang Liu, and Mei-Lan Hao
November 2004, Biochimica et biophysica acta,
An-Li Jiang, and Jian-Ye Zhang, and Charles Young, and Xiao-Yan Hu, and Yong-Mei Wang, and Zhi-Fang Liu, and Mei-Lan Hao
June 2004, Brain research. Molecular brain research,
An-Li Jiang, and Jian-Ye Zhang, and Charles Young, and Xiao-Yan Hu, and Yong-Mei Wang, and Zhi-Fang Liu, and Mei-Lan Hao
April 1996, Biochemical and biophysical research communications,
An-Li Jiang, and Jian-Ye Zhang, and Charles Young, and Xiao-Yan Hu, and Yong-Mei Wang, and Zhi-Fang Liu, and Mei-Lan Hao
July 2001, Gene,
Copied contents to your clipboard!